Ed Ross Email & Phone Number

Built and led team focused on development, sales and commercialization of custom medical devices, imaging/ planning services and surgical techniques addressing guided implant surgery serving the dental implant industry. Recipient of one of two companies in Massachusetts to receive $520,000 Accelerator Loan and winner of M2D2 Startup Award. Expertise in business development and sales, operations, medical education and new product development.

Lead specialized services firm in business development, partnerships, sales & marketing, strategy, licensing, execution market entry services and investment/ fundraising for companies with disruptive medical device, distribution and software technologies. Therapeutic and surgical/ nursing device technology spanning orthopedics, spine, neurosurgery, woundcare, infection control, general surgery, regenerative medicine, dental, imaging and pain management.

Carlsbad, California, Us

Initiated key operating unit focused on regenerative medicine earmarked by launch of innovative stem cell and tissue offering (PureGen). Built and directed core team of 14 sales, marketing and R&D managers. Directed all commercial and educational efforts via direct sales and independent distributors. Led negotiation of partner contracts and collaborations. Revamped complex operational processes associated with sales and procurement.

Billerica, Ma, Us

Built commercial operations for start-up orthopedic personalized medicine company with breakthrough technology. Defined and implemented foundation marketing strategy and brands for industry's first patient-specific ‘image-to-implant’ resurfacing platform entailing MRI and CT imaging. Led development and management of direct sales team (35), distributor network, customer service, training, medical education, reimbursement and KOLs in U.S. and Europe.

St Paul, Mn, Us

Built start-up disruptive wound / surgical closure company, leading sales, marketing and clinical efforts in plastic, cardiovascular, general, orthopedic, dermatology surgery & emergency medicine. Established and directed direct sales force, clinical and marketing/ service and medical education team. Launched two generations of closure device and systems to hospital and office markets. Tripled annual sales volume consistently. Achieved multiple awards including THE WALL STREET JOURNAL 2005 Technology Innovation Award for medical devices and 2005 MD&D MEDICAL DESIGN Excellence Award.

Founded and led strategy and customer acquisition and management for unique specialized firm focused on bringing US-based companies with products in clinical study for FDA clearance to international markets, establishing clinical advocates/ KOLs, education programs and defining/ leading sales channels. Defined and managed KOLs, clinical study sites and parameters, distribution channels and partners, outlined reimbursement considerations and plans for clients. Medical device product focus including dry macular degeneration (AMD), sterilization devices and products, surgical instrumentation, biomaterials, cardiovascular and wound healing.

Bedford, Ma, Us

Built global sales, marketing and business development including distribution alliances and channels. Led development and commercialization of regenerative medicine products including ophthalmic, orthopedic, spinal, sports medicine, dental, plastic surgery and wound healing. Co-directed public relations with CFO.• Increased top-line revenues from $3 to $16 million and reversed significant corporate loss into profitability. Led efforts with CEO and CFO to raise $20 million in secondary offering.• Negotiated and managed corporate and distribution alliances, including $26.5 million exclusive global distribution agreement with Zimmer, a division of Bristol-Myers Squibb, for osteoarthritis injectable in a $600 million market. Led further negotiations for future alliances with Johnson & Johnson ortho, Mitek and Depuy businesses.• Renegotiated major contracts with Chiron Vision and Bausch & Lomb, increasing sales from $3 to $10 million, establishing significant profitability and securing option to pursue an estimated $10 million in incremental business.

Defined and executed global go-to-market strategies and tactical sales plans as well as development and distribution alliances of proprietary wound management anti-adhesion (ADCON®) and glial-based CNS therapeutic technologies.• Built direct sales and independent distribution network and launch programs for European, Asian and pre-US launch.• Raised $20 million IPO with CEO and CFO, leading strategy development and go-to-market plans.

New York, New York, Us

Responsible for global commercial strategic plan, marketing, business and clinical plan development for rhBMP bone and tissue regeneration addressing a potential $1B market in orthopedic, spinal, cranio-maxillofacial/ dental & cartilage indications for one of first FDA combination device-biologic implant. Resulting product INFUSE, now $1B “gold standard” for bone fusion.• Created first corporate commercial platform in orthopedic and surgical markets, resulting in market leadership for brand and corporate visibility. Led development of clinical advisory board and clinical development strategies.• Led analysis, partner contact and negotiations with potential acquisitions and alliances, resulting in a $50 million collaboration with industry leader of spinal systems (Medtronic – Sofamor Danek) and a drug delivery agreement with biomaterials supplier (Integra Life Sciences) redirecting early project path resulting in InFuse product.

Warsaw, Indiana, Us

Led divisional globalization efforts as well as for business development, divisional strategy and acquisition activities for a $55M division.• Increased sales 42% by developing local and global new orthopedic and sports medicine product systems.• Drafted first divisional global strategic plan and organized senior management strategic task force.• Led partnership, development initiative and pre-market launch for industry’s first orthobiologics bone graft replacement.Initiated/ led marketing, technical sales, strategic planning team of 17 US team. Built and developed national technical sales force to increase distributor proficiency producing 40% sales increase. Initiated and directed division initiative to reduce product development cycles, resulting in creation of separate division.

Warsaw, Indiana, Us

Turned around fledgling, unprofitable stagnant and disrespected commodity-oriented product line into profitable, innovative, reliable systems provider, tripling sales in 3 years. Identified and led development of several new product systems in IM rods, hip, extremity and spinal fixation. Championed pursuit and acquisition of innovative tissue management technology, leading to establishment of sports medicine implant franchise. Expanded use of unique fixation systems into maxillofacial, neurosurgical, podiatric and veterinary markets.